APA (7th ed.) Citation

H, R., WC, C., YH, K., HC, T., YC, F., JH, G., . . . CH, T. (2026). Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis. European journal of pharmacology, 1029, 179022. https://doi.org/10.1016/j.ejphar.2026.179022

Chicago Style (17th ed.) Citation

H, Rengamanar, et al. "Ergostatrien-3β-ol Suppresses Breast Cancer Anoikis Resistance and Metastasis by Targeting the MiR-93-5p/leupaxin Axis." European Journal of Pharmacology 1029 (2026): 179022. https://doi.org/10.1016/j.ejphar.2026.179022.

MLA (9th ed.) Citation

H, Rengamanar, et al. "Ergostatrien-3β-ol Suppresses Breast Cancer Anoikis Resistance and Metastasis by Targeting the MiR-93-5p/leupaxin Axis." European Journal of Pharmacology, vol. 1029, 2026, p. 179022, https://doi.org/10.1016/j.ejphar.2026.179022.